5-Bromo-3-chloro-2-(difluoromethyl)pyridine, 250mg

4-(3-Bromo-phenyl)-3-chlorosulfonyl-5-trifluoromethyl-thiophene-2-carboxylic acid methyl ester, 95.0%, 1g

2-Amino-5-nitrothiazole, 97.0%, 25g

Larotrectinib, 97%, 10mg

Di-tert-butyl(2',4',6'-triisopropyl-3,6-dimethoxy-[1,1'-biphenyl]-2-yl)phosphine>98.0%(T)(qNMR)250mg

(R)-3-((tert-Butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid, 95.0%, 50mg

N-(4-Bromophenyl)-4-biphenylamine, 95.0%, 5g

(2S,3S,4R,5R,6R)-6-(Acetoxymethyl)-3-hydroxytetrahydro-2H-pyran-2,4,5-triyl triacetate, 95.0%, 25g

5-Chloromethyl-3-(4-methoxyphenyl)-[1,2,4]oxadiazole, 95.0%, 250mg

2-BUTYL-1,3-THIAZOLE-4-CARBOXYLIC ACID, 95%, 10g

3-CHLORO-6-NITRO-1H-INDAZOLE, 97%, 25g

Fmoc-(S)-3-Amino-4-(2-chlorophenyl)-butyric acid, 97%, 100mg

5-Phenyl-1H-imidazole-2-carboxylic acid, 95.0%, 100mg